SlideShare uma empresa Scribd logo
1 de 8
Risk-based approach in:
definition and classification of deficiencies
• Deficiencies are descriptions of non-compliance with GMP requirements.
A distinction is made between deficiencies as a result of: -
– a defective system or,
– failure to comply with the system.
• Deficiencies may be classified as: – Critical Observation – potential risk harm to the user – Major
Observation – major deviation from GMP/GCP – Minor or Other Observation – departure from good
practice
Classification of observations
Critical Observation
•An observation that has produced, or may result in a significant risk of producing, an API that, when
used in a finished product, is harmful to the user.
Major Observation
A non-critical observation that:
•has produced or may produce a product which does not comply with its prequalification application
(including variations); and/or
•indicates a major deviation from the GMP guide; and/or
•indicates a failure to carry out satisfactory procedures for release of batches; and/or
•indicates a failure of the person responsible for QA/QC to fulfill his/her duties; and/or
•consists of several other deficiencies, none of which on its own may be major, but which may together
represent a major deficiency and should be explained and reported as such.
Other Observation
•An observation that cannot be classified as either critical or major, but indicates a departure from good
manufacturing practice.
•A deficiency may be “other” either because it is judged as minor, or because there is insufficient
information to classify it as major or critical.
Pfizer 10 Step Process
Pfizer 10 step process13p
1. Collect & Organize the information
Gathering relevant information, reviewing appropriate references &
identifying assumptions
Tools can be used to organize the information
Define the boundaries of the QRM exercise
2. Formulate the Risk Question:
Starting point of the QRM exercise, high level statement outlining
the issue & purpose for conducting the QRM exercise including risk
factors, the scope of the issue and any related limits or constraints
Example: What is the supplier audit schedule that will ensure that suppliers
presenting a high risk to the patient are audited in a more frequent manner?
3. Choose Tool
Basic risk management facilitation methods (flowcharts, check sheets
etc)
Failure Mode Effects Analysis & Failure Mode Effects & Criticality
Analysis
Fault Tree Analysis
Hazard Analysis & Critical Control Points
Hazard & Operability Analysis
Preliminary Hazard Analysis
Risk Ranking & Filtering
Supporting statistical tools
 Risk Management Tool adapted from The development of a Quality Risk
Management solution designed to facilitate compliance with the risk‐based
qualification, validation and change control GMP requirement of the EU.
Dublin :
Dublin Institute of Technology, 2007 . Kevin O'Donnell PhD
4. Identify Risks Factors and Related Hazards:
What are the Risk Factors (patient safety, compliance and business) arising from
all
potential hazards identified?
5. Define the Risk Components & Scales
What does Severity, Probability & Detection mean in terms of this Risk
Question?
In terms of a QRM exercise to create a supplier audit schedule
Severity ‐ Criticality of the product
Probability ‐ Complexity of the site (multi‐product)
Detection ‐ Audit history
Severity Scale
Factor Definition
10 Sterile products
6 Product orally administered
3 Topical products and compounds not directly used by
patient
1 Compounds used during manufacturing process
6. Create matrix
7. Determine Action Threshold
•A level or value above which an action will take place and below which it will not
8. Apply the tool
• Analyze the detailed risks and quantify those risks using the scales for
severity, probability and detection to provide a risk score
•Determine what actions are required based on the threshold for action
9. Define Risk Mitigation
Consider measures/actions that could:
Decrease the severity
 stop failure before significant consequences, reject, recall
Decrease the probability
 Inspect defect out of batch
Increase the detection
 Move from manual to machine inspection
Reapply the tool taking the mitigating measures into consideration
Determine if the mitigations/actions have introduced new risks
10. Document and Approve
•Document and approve in a Quality Risk Assessment Report

Mais conteúdo relacionado

Mais procurados

GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviationDr. Amsavel A
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validationBangaluru
 
GMP (Good Manufacturing Practice) presentation
GMP (Good Manufacturing Practice) presentation GMP (Good Manufacturing Practice) presentation
GMP (Good Manufacturing Practice) presentation Durrani Yousuf Khan
 
Market complaints and product recall
Market complaints and product recallMarket complaints and product recall
Market complaints and product recallpaideeksha
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fdaFasika Mekete
 
Audits in pharmaceutical industry
Audits in pharmaceutical industryAudits in pharmaceutical industry
Audits in pharmaceutical industryVikramMadane1
 
Overview of computer system validation
Overview of computer system validationOverview of computer system validation
Overview of computer system validationNilesh Damale
 
BPR review and batch release
BPR review and batch release BPR review and batch release
BPR review and batch release Dr. Amsavel A
 
Good Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety ConsultancyGood Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety ConsultancyAtlantic Training, LLC.
 
Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical
 
21 cfr part 210 and 211
21 cfr part 210 and 21121 cfr part 210 and 211
21 cfr part 210 and 211Bhanu Chava
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. AmsavelDr. Amsavel A
 

Mais procurados (20)

GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
 
Deviation QA
Deviation QADeviation QA
Deviation QA
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validation
 
GMP (Good Manufacturing Practice) presentation
GMP (Good Manufacturing Practice) presentation GMP (Good Manufacturing Practice) presentation
GMP (Good Manufacturing Practice) presentation
 
Change control
Change controlChange control
Change control
 
Market complaints and product recall
Market complaints and product recallMarket complaints and product recall
Market complaints and product recall
 
Process validation fda
Process validation fdaProcess validation fda
Process validation fda
 
Product quality review
Product quality reviewProduct quality review
Product quality review
 
Gmp
GmpGmp
Gmp
 
Audits in pharmaceutical industry
Audits in pharmaceutical industryAudits in pharmaceutical industry
Audits in pharmaceutical industry
 
calulation of yields, production record review,change control
calulation of yields, production record review,change control calulation of yields, production record review,change control
calulation of yields, production record review,change control
 
Overview of computer system validation
Overview of computer system validationOverview of computer system validation
Overview of computer system validation
 
BPR review and batch release
BPR review and batch release BPR review and batch release
BPR review and batch release
 
Good Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety ConsultancyGood Manufacturing Practices Training by International Food Safety Consultancy
Good Manufacturing Practices Training by International Food Safety Consultancy
 
Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment
 
FDA GMP Training - The Quality Audit
FDA GMP Training - The Quality AuditFDA GMP Training - The Quality Audit
FDA GMP Training - The Quality Audit
 
Changeover Clearance
Changeover ClearanceChangeover Clearance
Changeover Clearance
 
21 cfr part 210 and 211
21 cfr part 210 and 21121 cfr part 210 and 211
21 cfr part 210 and 211
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
 
Line clearance ppt
Line clearance pptLine clearance ppt
Line clearance ppt
 

Destaque

Destaque (7)

Top 20 observation series # 5 21 CFR 211.100
Top 20 observation series # 5   21 CFR 211.100Top 20 observation series # 5   21 CFR 211.100
Top 20 observation series # 5 21 CFR 211.100
 
Quality audits
Quality auditsQuality audits
Quality audits
 
Pharmaceutical Deviation SOP
Pharmaceutical Deviation SOPPharmaceutical Deviation SOP
Pharmaceutical Deviation SOP
 
Capa The Challenge And Solution
Capa The Challenge And SolutionCapa The Challenge And Solution
Capa The Challenge And Solution
 
Corrective Action & Preventive Action
Corrective Action & Preventive ActionCorrective Action & Preventive Action
Corrective Action & Preventive Action
 
CAPA Training Presentation
CAPA Training PresentationCAPA Training Presentation
CAPA Training Presentation
 
Back To Basic Gmp
Back To Basic GmpBack To Basic Gmp
Back To Basic Gmp
 

Semelhante a Risk minor major critical

An Introduction To Risk Management Professional Societies
An Introduction To Risk Management   Professional SocietiesAn Introduction To Risk Management   Professional Societies
An Introduction To Risk Management Professional Societiesmkaufer
 
2014_NVF_III_Session_3_Risk_Assessment.pdf
2014_NVF_III_Session_3_Risk_Assessment.pdf2014_NVF_III_Session_3_Risk_Assessment.pdf
2014_NVF_III_Session_3_Risk_Assessment.pdfGobu Devarajan
 
Quality risk management
Quality risk managementQuality risk management
Quality risk managementKarunaMane1
 
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)saimsoleja
 
Presentation: Quality risk management issues
Presentation: Quality risk management issuesPresentation: Quality risk management issues
Presentation: Quality risk management issuesTGA Australia
 
Ich guidelines on risk assessment and risk mangment
Ich guidelines on risk assessment and risk mangmentIch guidelines on risk assessment and risk mangment
Ich guidelines on risk assessment and risk mangmentAshvin Bhoge
 
Quality Risk Management.pptx
Quality Risk Management.pptxQuality Risk Management.pptx
Quality Risk Management.pptxSyedMohammadRahat
 
Quality management system(qrm)
Quality management system(qrm)Quality management system(qrm)
Quality management system(qrm)DPSRU,NEW DELHI
 
Focus on FDA cGMPs inspections
Focus on FDA cGMPs inspections Focus on FDA cGMPs inspections
Focus on FDA cGMPs inspections JinalPrajapati13
 
Quality Risk Management 2 brief note
Quality  Risk Management 2 brief noteQuality  Risk Management 2 brief note
Quality Risk Management 2 brief noteRathodBhavansinh
 
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideOverview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideProPharma Group
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryMahesh shinde
 
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalCRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalManjusha Chowdhury
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Managementmuna_ali
 

Semelhante a Risk minor major critical (20)

An Introduction To Risk Management Professional Societies
An Introduction To Risk Management   Professional SocietiesAn Introduction To Risk Management   Professional Societies
An Introduction To Risk Management Professional Societies
 
2014_NVF_III_Session_3_Risk_Assessment.pdf
2014_NVF_III_Session_3_Risk_Assessment.pdf2014_NVF_III_Session_3_Risk_Assessment.pdf
2014_NVF_III_Session_3_Risk_Assessment.pdf
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Presentation: Quality risk management issues
Presentation: Quality risk management issuesPresentation: Quality risk management issues
Presentation: Quality risk management issues
 
ICH Q9 Guidelines
ICH Q9 GuidelinesICH Q9 Guidelines
ICH Q9 Guidelines
 
Ich guidelines on risk assessment and risk mangment
Ich guidelines on risk assessment and risk mangmentIch guidelines on risk assessment and risk mangment
Ich guidelines on risk assessment and risk mangment
 
Quality Risk Management.pptx
Quality Risk Management.pptxQuality Risk Management.pptx
Quality Risk Management.pptx
 
Quality management system(qrm)
Quality management system(qrm)Quality management system(qrm)
Quality management system(qrm)
 
Audits
AuditsAudits
Audits
 
Focus on FDA cGMPs inspections
Focus on FDA cGMPs inspections Focus on FDA cGMPs inspections
Focus on FDA cGMPs inspections
 
Quality Risk Management 2 brief note
Quality  Risk Management 2 brief noteQuality  Risk Management 2 brief note
Quality Risk Management 2 brief note
 
Data, Information & Knowledge Integration
Data, Information & Knowledge IntegrationData, Information & Knowledge Integration
Data, Information & Knowledge Integration
 
CRO - Clinical Vendor Oversight Webinar.
CRO - Clinical Vendor Oversight Webinar.CRO - Clinical Vendor Oversight Webinar.
CRO - Clinical Vendor Oversight Webinar.
 
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideOverview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical Industry
 
CRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: ClinicalCRO and Vendor Oversight: Clinical
CRO and Vendor Oversight: Clinical
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
HACCP PRESENTATION
HACCP PRESENTATIONHACCP PRESENTATION
HACCP PRESENTATION
 

Risk minor major critical

  • 1. Risk-based approach in: definition and classification of deficiencies • Deficiencies are descriptions of non-compliance with GMP requirements. A distinction is made between deficiencies as a result of: - – a defective system or, – failure to comply with the system. • Deficiencies may be classified as: – Critical Observation – potential risk harm to the user – Major Observation – major deviation from GMP/GCP – Minor or Other Observation – departure from good practice Classification of observations Critical Observation •An observation that has produced, or may result in a significant risk of producing, an API that, when used in a finished product, is harmful to the user. Major Observation A non-critical observation that: •has produced or may produce a product which does not comply with its prequalification application (including variations); and/or •indicates a major deviation from the GMP guide; and/or •indicates a failure to carry out satisfactory procedures for release of batches; and/or •indicates a failure of the person responsible for QA/QC to fulfill his/her duties; and/or •consists of several other deficiencies, none of which on its own may be major, but which may together represent a major deficiency and should be explained and reported as such. Other Observation •An observation that cannot be classified as either critical or major, but indicates a departure from good manufacturing practice. •A deficiency may be “other” either because it is judged as minor, or because there is insufficient information to classify it as major or critical.
  • 2.
  • 3.
  • 4.
  • 5. Pfizer 10 Step Process Pfizer 10 step process13p 1. Collect & Organize the information Gathering relevant information, reviewing appropriate references & identifying assumptions Tools can be used to organize the information Define the boundaries of the QRM exercise 2. Formulate the Risk Question: Starting point of the QRM exercise, high level statement outlining the issue & purpose for conducting the QRM exercise including risk factors, the scope of the issue and any related limits or constraints Example: What is the supplier audit schedule that will ensure that suppliers presenting a high risk to the patient are audited in a more frequent manner? 3. Choose Tool Basic risk management facilitation methods (flowcharts, check sheets etc) Failure Mode Effects Analysis & Failure Mode Effects & Criticality Analysis Fault Tree Analysis Hazard Analysis & Critical Control Points Hazard & Operability Analysis Preliminary Hazard Analysis Risk Ranking & Filtering Supporting statistical tools  Risk Management Tool adapted from The development of a Quality Risk Management solution designed to facilitate compliance with the risk‐based
  • 6. qualification, validation and change control GMP requirement of the EU. Dublin : Dublin Institute of Technology, 2007 . Kevin O'Donnell PhD 4. Identify Risks Factors and Related Hazards: What are the Risk Factors (patient safety, compliance and business) arising from all potential hazards identified? 5. Define the Risk Components & Scales What does Severity, Probability & Detection mean in terms of this Risk Question? In terms of a QRM exercise to create a supplier audit schedule Severity ‐ Criticality of the product Probability ‐ Complexity of the site (multi‐product) Detection ‐ Audit history Severity Scale Factor Definition 10 Sterile products 6 Product orally administered 3 Topical products and compounds not directly used by patient 1 Compounds used during manufacturing process
  • 7. 6. Create matrix 7. Determine Action Threshold •A level or value above which an action will take place and below which it will not 8. Apply the tool • Analyze the detailed risks and quantify those risks using the scales for severity, probability and detection to provide a risk score •Determine what actions are required based on the threshold for action
  • 8. 9. Define Risk Mitigation Consider measures/actions that could: Decrease the severity  stop failure before significant consequences, reject, recall Decrease the probability  Inspect defect out of batch Increase the detection  Move from manual to machine inspection Reapply the tool taking the mitigating measures into consideration Determine if the mitigations/actions have introduced new risks 10. Document and Approve •Document and approve in a Quality Risk Assessment Report